SM
BMY icon

SG3 Management’s Bristol-Myers Squibb BMY Stock Holding History

SG3 Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-250
Closed -$16.3K – 1043
2021
Q1 		$16K Sell
250
-750
-75% -$46.7K ﹤0.01% 1117
2020
Q4 		$62K Hold
1,000
– – ﹤0.01% 954
2020
Q3 		$60K Buy
1,000
+100
+11% +$6.02K ﹤0.01% 823
2020
Q2 		$53K Sell
900
-20,200
-96% -$1.21M ﹤0.01% 561
2020
Q1 		$1.18M Buy
21,100
+1,100
+6% +$67.2K 0.16% 94
2019
Q4 		$1.28M Buy
+20,000
New +$1.15M 0.08% 88
2018
Q2 		– Sell
-45,000
Closed -$2.85M – 114
2018
Q1 		$2.85M Buy
+45,000
New +$2.89M 1.17% 24

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

SG3 Management's BMY Position: Q2 2021 in Review

SG3 Management sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 250 shares — an estimated $16.3K sold.

SG3 Management first reported a position in BMY in Q1 2018 and held it in 7 quarters. The position peaked at $2.85M in Q1 2018. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • SG3 Management reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
  • SG3 Management sold 250 Bristol-Myers Squibb shares in Q2 2021, an estimated $16.3K.
  • SG3 Management first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 7 quarters.
  • SG3 Management's Bristol-Myers Squibb position peaked at $2.85M in Q1 2018.
  • 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on SG3 Management's 13F filing for Q2 2021, filed 16 Aug 2021.